<DOC>
	<DOCNO>NCT00255697</DOCNO>
	<brief_summary>RATIONALE : Studying quality-of-life patient cancer treatment caregiver may help identify intermediate- long-term effect treatment patient cancer caregiver . PURPOSE : This clinical trial study quality life old patient undergoing treatment cancer family caregiver .</brief_summary>
	<brief_title>Quality Life Older Patients Who Are Undergoing Treatment Cancer Their Family Caregivers</brief_title>
	<detailed_description>OBJECTIVES : - Obtain quality life psychosocial data old patient undergoing treatment cancer family caregiver . OUTLINE : This pilot , cross-sectional study . Patients undergo 45-minute interview person phone provide demographic data complete quality life questionnaire , include Functional Assessment Cancer Therapy ( FACT ) , Spiritual tool , Quality Satisfaction Treatment ( QUEST ) , Profile Mood State ( POMS ) , baseline 3 12 month . Caregivers undergo 20- 30-minute interview person phone provide demographic data complete quality life questionnaire , include Caregiver Reaction Assessment ( CRA ) , Quest , POMS , baseline 3 12 month . Caregivers complete Quality Death Dying ( QODD ) questionnaire 2-3 month patient 's death . PROJECTED ACCRUAL : Not specify</detailed_description>
	<criteria>DISEASE CHARACTERISTICS : Patient : Confirmed diagnosis type cancer Undergoing cancer treatment Ireland Cancer Center Caregiver : Identified family caregiver patient diagnose cancer Patient caregiver may participate regardless whether person agree participate PATIENT CHARACTERISTICS : Performance status ECOG 03 ( patient ) Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other Able speak comprehend English Cognitively competent interview ( patient ) PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>psychosocial effect cancer treatment</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>